Immunology and Microbiology
Allele
18%
Allotransplantation
15%
Antigen Expression
16%
Antigen Presentation
16%
B Cell
97%
B Lymphocyte Subpopulation
11%
Blood Plasma
16%
CD4
26%
CD8
13%
Cell Growth
11%
Cell Line
28%
Cell Membrane
11%
Cell Population
19%
Chemokine
19%
Cytokine
21%
Cytotoxic T-Cell
10%
Cytotoxicity
16%
Epstein Barr Virus
59%
Gene Expression
16%
Genome-Wide Association Study
10%
Germinal Center
26%
Hodgkin Lymphoma Cell Line
36%
Human Leukocyte Antigen
42%
Immune Escape
16%
Immune Response
19%
Immunoprecipitation
11%
Intestine
11%
Leukemia Cell
11%
Lymphocyte
57%
Lymphoma Cell
12%
Molecular Weight
10%
Monoclonal Antibody
36%
Monocyte
10%
Monospecific Antibody
14%
Mouse
9%
Natural Killer Cell
21%
Placenta
10%
Protein Binding
10%
Receptor Type Tyrosine Protein Phosphatase C
28%
Reed Sternberg Cell
71%
Regulatory T Cell
10%
Surface Property
11%
T Cell
100%
T Cell Receptor
16%
T Cell Subset
10%
T Lymphocyte Subpopulation
10%
T-Helper Cell
19%
Thymus and Activation Regulated Chemokine
31%
Transcription Factors
13%
Tumor Cell
54%
Medicine and Dentistry
Alkaline Phosphatase
11%
Anaplastic Large Cell Lymphoma
10%
Antigen Expression
7%
B Cell
43%
B-Cell Chronic Lymphocytic Leukemia
6%
B-Cell Lymphoma
18%
Cancer
13%
CD8 Antigen
14%
Cell Cycle
9%
Cell Line
10%
Classical Hodgkin Lymphoma
55%
Colorectal Liver Metastasis
10%
Cytotoxic T-Cell
7%
Diffuse Large B-Cell Lymphoma
32%
Disease
11%
DNA Damage
10%
Epstein Barr Virus
17%
Epstein-Barr Virus
11%
Gene Expression
14%
Germinal Center
10%
Hairy Cell Leukemia
17%
Hodgkin Lymphoma Cell Line
12%
Hodgkin's Lymphoma
57%
Human Leukocyte Antigen
26%
Immune Checkpoint Inhibitor
10%
Immunohistochemistry
14%
Immunophenotyping
7%
Immunoprecipitation
7%
In Vitro
8%
Lymphadenopathy
15%
Lymphocyte
13%
Macrophage
11%
Metalloproteinase
7%
Monoclonal Antibody
19%
Neoplasm
25%
Nodular Lymphocyte Predominant Hodgkin's Lymphoma
23%
Non-Hodgkin Lymphoma
12%
Positron Emission Tomography
10%
Prematurity
10%
Protein Expression
8%
Reed-Sternberg Cell
14%
T Cell
51%
T Cell Subset
6%
Thymus and Activation Regulated Chemokine
10%
Transplantation
8%
Tumor Cell
35%
Tumor Microenvironment
7%
Tumor Necrosis Factor Alpha Converting Enzyme
10%
Tumor Progression
6%
Upregulation
10%
Keyphrases
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
10%
Activated T Cells
6%
Activation-regulated Chemokine
10%
AZD1775
6%
B Cells
18%
CD26
6%
CD4+
6%
CD4+ T Cells
6%
CD45
7%
CD57
5%
CD58
5%
Cell-to-cell
5%
Cellular Origin
5%
Classical Hodgkin Lymphoma
34%
Diffuse Large B-cell Lymphoma (DLBCL)
11%
Epstein-Barr Virus
6%
Galectin-1 (Gal-1)
8%
Gene Rearrangement
5%
Hairy Cell Leukemia
6%
HLA Class I Expression
10%
HLA Class II
6%
Hodgkin Disease
13%
Hodgkin Lymphoma
18%
Human Leukocyte Antigen
10%
Human Leukocyte Antigen Class I
5%
Human Leukocyte Antigen Class II
9%
Immune Disorders
5%
Immunohistochemistry
5%
Leukocyte Common Antigen
7%
Lymphoma
5%
Lymphoma Cells
7%
Lymphoma Patients
10%
Microenvironment
17%
Monoclonal Antibody
5%
Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)
11%
Non-Hodgkin Lymphoma
8%
Normal B Cells
5%
Phorbol Ester
6%
Postnatal Change
5%
Prognostic Marker
6%
Reed-Sternberg Cells
8%
Refractory Hodgkin Lymphoma
5%
Rosette
7%
T Cells
21%
T-cell Profile
5%
Thymus
10%
Tonsil
5%
Treatment Response
7%
Tumor
6%
Tumor Cells
13%
